Loading market data...
The Gaudium IVF and Women Health IPO opened on February 20 with strong retail participation, achieving 0.90x subscription on Day 1. The ₹165 crore issue, priced between ₹75 and ₹79 per share, saw the retail category oversubscribed at 1.36x, while the NII segment stood at 0.90x. The company plans to use the proceeds for expansion of IVF centers and investment in subsidiaries. With India’s fertility services sector witnessing steady growth, investor focus now shifts to QIB participation and overall subscription momentum before the February 23 closing.
The IPO of Gaudium IVF and Women Health opened on February 20 with a solid response, achieving 0.90x subscription on Day 1. Retail investors led the charge with 1.36x subscription, while the NII portion stood at 0.90x. The company aims to raise ₹165 crore through a mix of fresh issue and offer-for-sale. With expansion plans in the high-growth fertility treatment sector, investor attention now shifts to the QIB segment performance.
The initial public offering of Gaudium IVF and Women Health has begun on a promising note, drawing strong retail interest on its opening day.
By market close:
The early response signals positive investor sentiment, particularly within the retail category.
| Investor Category | Subscription Status |
|---|---|
| Retail Investors | 1.36x |
| Non-Institutional Investors (NII) | 0.90x |
| Qualified Institutional Buyers (QIB) | Yet to open |
Retail oversubscription often reflects confidence in business fundamentals and future growth potential.
| Particulars | Details |
|---|---|
| Issue Size | ₹165 crore |
| Price Band | ₹75 – ₹79 per share |
| Fresh Issue | 1.13 crore shares |
| Offer for Sale (OFS) | 94.93 lakh shares |
| IPO Closing Date | February 23 |
The IPO includes a fresh capital raise and an offer-for-sale by promoter Dr. Manika Khanna.
Post-IPO, her stake will reduce from 99.32% to 70.73%, while she retains majority control.
The company plans to deploy IPO proceeds toward:
Expansion into new geographies could strengthen brand presence in India’s rapidly growing fertility services market.
India’s fertility services industry is expanding due to:
The IVF market in India is witnessing steady growth, supported by:
| Growth Drivers | Impact |
|---|---|
| Increasing disposable income | Higher treatment affordability |
| Medical tourism | International patient inflows |
| Technology upgrades | Higher success rates |
| Awareness campaigns | Greater adoption |
This structural tailwind strengthens the long-term outlook for players like Gaudium IVF.
While detailed financial metrics from the red herring prospectus are key for valuation assessment, investors are closely tracking:
Healthcare IPOs often attract premium valuations when backed by scalable expansion strategies.
The strong retail participation on Day 1 indicates optimism.
However, IPO success often hinges on:
If the QIB segment sees strong bidding, it could significantly boost overall subscription momentum.
| Risk Factor | Potential Impact |
|---|---|
| Regulatory compliance | Operational scrutiny |
| Competitive intensity | Margin pressure |
| Expansion execution | Capital efficiency risk |
| Market volatility | Listing performance fluctuation |
Healthcare service businesses require sustained operational excellence to justify valuation multiples.
Gaudium IVF’s listing represents:
As India’s healthcare sector formalizes and expands, specialized service providers may attract long-term investor attention.
With the IPO open until February 23:
If subscription strengthens across categories, listing day performance could see healthy investor participation.
The Gaudium IVF IPO has begun with encouraging momentum, led by strong retail demand. Backed by expansion plans and sector growth tailwinds, the company is positioning itself to capitalize on rising fertility treatment demand in India.
Investors should monitor QIB response, financial disclosures, and valuation metrics before making decisions.
⚠️ DISCLAIMER: This article is for informational purposes only and does not constitute investment advice.
Financial journalist specializing in market analysis, stock research, and investment trends. Dedicated to providing accurate, timely insights for informed decision-making.
Credentials: Experienced financial journalist with expertise in equity markets and economic analysis
The information provided in this article is for educational and informational purposes only and should not be construed as financial, investment, or legal advice. Finscann does not provide personalized investment recommendations.
For detailed terms and conditions, please read our Disclaimer and Terms of Service.
PNGS Reva Diamond Jewellery’s ₹380 crore IPO opens with a modest 3% GMP. Check price band, financial performance, EBITDA margins, valuation analysis,...
Clean Max Enviro Energy Solutions IPO on February 23, 2026, garnered 34% subscription on Day 1, with strong QIB interest.
Discover the 9 most anticipated IPOs worth ₹4,400 Cr hitting the Indian market this week in February 2026.
Shree Ram Twistex IPO opens February 23, 2026, offering 1.06 crore shares at ₹95-₹104. FinScann provides critical analysis, financials, and market...
Clean Max Enviro Energy Solutions IPO opens today, February 23, 2026. Discover crucial details, financial analysis, market impact, and FinScann's...